Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
8.60B | 8.56B | 7.36B | 5.52B | 5.20B | 4.88B | Gross Profit |
3.23B | 3.21B | 2.72B | 2.08B | 1.98B | 1.83B | EBIT |
1.05B | 1.07B | 652.00M | 622.00M | 585.00M | 495.00M | EBITDA |
1.75B | 1.63B | 1.15B | 755.00M | 853.00M | 736.00M | Net Income Common Stockholders |
906.00M | 890.00M | 609.00M | 355.00M | 427.00M | 254.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.06B | 1.12B | 1.02B | 944.00M | 1.35B | 1.88B | Total Assets |
16.56B | 16.50B | 16.11B | 7.95B | 8.28B | 8.75B | Total Debt |
2.14B | 2.02B | 2.39B | 1.95B | 2.44B | 3.08B | Net Debt |
1.08B | 895.00M | 1.37B | 1.00B | 1.09B | 1.21B | Total Liabilities |
5.50B | 5.62B | 5.94B | 4.45B | 5.05B | 5.77B | Stockholders Equity |
10.82B | 10.64B | 10.17B | 3.49B | 3.22B | 2.97B |
Cash Flow | Free Cash Flow | ||||
889.00M | 942.00M | 566.00M | 388.00M | 330.00M | 641.00M | Operating Cash Flow |
1.21B | 1.26B | 837.00M | 596.00M | 538.00M | 824.00M | Investing Cash Flow |
-446.00M | -482.00M | -628.00M | -191.00M | -183.00M | -169.00M | Financing Cash Flow |
-649.00M | -615.00M | -157.00M | -790.00M | -855.00M | 473.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $16.63B | 26.07 | 18.59% | 0.95% | -0.42% | 3.23% | |
78 Outperform | $8.15B | 27.95 | 17.61% | 0.70% | 3.89% | 8.17% | |
77 Outperform | $406.57M | 44.72 | 8.41% | ― | 11.22% | 229.35% | |
76 Outperform | $4.01B | 27.99 | 17.68% | 1.02% | 10.96% | 43.44% | |
72 Outperform | $31.16B | 34.44 | 8.62% | 1.16% | 8.14% | 32.64% | |
70 Outperform | $6.75B | 24.21 | 14.00% | 1.63% | 4.23% | 20.40% | |
64 Neutral | $4.43B | 12.01 | 5.16% | 249.23% | 4.03% | -11.73% |
On May 13, 2025, Xylem Inc. held its Annual Meeting of Shareholders, where 88.68% of the company’s outstanding common stock was represented. Key outcomes included the election of nine directors, ratification of Deloitte & Touche LLP as the independent auditor for 2025, approval of executive compensation, and the rejection of a shareholder proposal for special shareholder meeting improvements.
The most recent analyst rating on (XYL) stock is a Buy with a $148.00 price target. To see the full list of analyst forecasts on Xylem stock, see the XYL Stock Forecast page.
Spark’s Take on XYL Stock
According to Spark, TipRanks’ AI Analyst, XYL is a Outperform.
Xylem’s overall stock score of 72 reflects its strong financial performance, particularly in terms of profitability and cash flow management. The technical indicators suggest a neutral to slightly negative momentum, while the valuation indicates a high price relative to earnings. The positive guidance from the recent earnings call boosts confidence, despite challenges in specific markets and tariff-related uncertainties.
To see Spark’s full report on XYL stock, click here.